{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:59Z","timestamp":1787010179309,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5,12]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Atorvastatin is a commonly used statin for the treatment of hypercholesterolemia in people at high risk for coronary, cerebrovascular, and peripheral artery disease. However, fatal liver failure due to atorvastatin treatment has been rarely reported, especially during the very short incubation period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 63-year-old male patient was admitted due to unexplained chest pain. After admission, his liver function had decreased &lt; 24 hours after taking 20\u2009mg tablets of atorvastatin due to lacunar infarction, which was improved after drug withdrawal. The treatment regimen was restarted 15 days later, but within 16 hours, the patient developed multiple organ failure, including liver failure and renal failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The pathological results after 7 days indicated focal inflammatory necrosis, virus and autoimmune correlation tests were negative, which did not rule out drug-induced liver injury. Interventions: receiving artificial liver therapy, continuous renal replacement therapy and other organ support treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient died 18 days after admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Statin idiosyncratic liver injury is very rare, but the consequences can be serious.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000033743","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T10:21:22Z","timestamp":1683886882000},"page":"e33743","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Fatal hepatic failure following atorvastatin treatment: A case report"],"prefix":"10.1097","volume":"102","author":[{"given":"Huajun","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Intensive Care Unit, The Affiliated People\u2019s Hospital of Ningbo University, Ningbo City, Zhejiang Province, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, The Affiliated People\u2019s Hospital of Ningbo University, Ningbo City, Zhejiang Province, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjie","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, The Affiliated People\u2019s Hospital of Ningbo University, Ningbo City, Zhejiang Province, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, The Affiliated People\u2019s Hospital of Ningbo University, Ningbo City, Zhejiang Province, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejim.2021.10.035","article-title":"Drug-induced liver injury: pathogenesis, epidemiology, clinical features, and practical management.","volume":"97","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Eur J Intern Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cld.2019.09.007","article-title":"Drug-induced liver injury from statins.","volume":"24","author":"Meurer","year":"2020","journal-title":"Clin Liver Dis"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e931418","DOI":"10.12659\/AJCR.931418","article-title":"Hepatotoxicity induced by fluvastatin: a reversible acute cholestatic liver injury.","volume":"22","author":"Alanazi","year":"2021","journal-title":"Am J Case Rep"},{"key":"R4-20250504","first-page":"1","article-title":"Risk factors and morbidity associated with surgical site infection subtypes following adult neurosurgical procedures.","volume":"29","author":"Adapa","year":"2021","journal-title":"Br J Neurosurg"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40266-019-00736-y","article-title":"The safety and tolerability of statin therapy in primary prevention in older adults: a systematic review and meta-analysis.","volume":"37","author":"Zhou","year":"2020","journal-title":"Drugs Aging"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/14740338.2020.1796966","article-title":"Statin use and safety concerns: an overview of the past, present, and the future.","volume":"19","author":"Mulchandani","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"3 Suppl","key":"R7-20250504","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jacl.2014.02.011","article-title":"An assessment by the statin liver safety task force: 2014 update.","volume":"8","author":"Bays","year":"2014","journal-title":"J Clin Lipidol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/gutjnl-2019-318237","article-title":"Cirrhosis as new indication for statins.","volume":"69","author":"Bosch","year":"2020","journal-title":"Gut"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jhep.2021.12.034","article-title":"Statin exposure is associated with reduced development of acute-on-chronic liver failure in a Veterans affairs cohort.","volume":"76","author":"Mahmud","year":"2022","journal-title":"J Hepatol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14740338.2018.1394455","article-title":"Statin drug interactions and related adverse reactios: an update.","volume":"17","author":"Bellosta","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jacl.2021.09.050","article-title":"Association of patient, provider and facility related characteristics with statin associated side effects and statin use: insight from the Veteran\u2019s Affairs healthcare system.","volume":"15","author":"Jia","year":"2021","journal-title":"J Clin Lipidol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2011.07.023","article-title":"Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.","volume":"56","author":"Bj\u00f6rnsson","year":"2012","journal-title":"J Hepatol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study.","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12876-018-0858-z","article-title":"Suspected drug-induced liver injury associated with iguratimod: a case report and review of the literature.","volume":"18","author":"Li","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1097\/MJT.0000000000000012","article-title":"Drug-induced acute liver injury within 12 hours after Fluvastatin therapy.","volume":"23","author":"Li","year":"2016","journal-title":"Am J Ther"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1515\/aiht-2017-68-2994","article-title":"Hepatotoxicity associated with statins.","volume":"68","author":"Karahalil","year":"2017","journal-title":"Arh Hig Rada Toksikol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2018.10.004","article-title":"Statins: adverse reactions, oxidative stress and metabolic interactions.","volume":"195","author":"Liu","year":"2019","journal-title":"Pharmacol Ther"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2015.12.017","article-title":"Adverse drug reactions and organ damage: the liver.","volume":"28","author":"Licata","year":"2016","journal-title":"Eur J Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T22:26:14Z","timestamp":1746311174000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":18,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033743","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,12]]}}}